Intensive glucose-lowering results in increased cardiovascular mortality in younger but not older individuals with type 2 diabetes

Affiliations

¹ Department of Emergency and Organ Transplantation, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Piazza Giulio Cesare, 11, Bari 70124, Italy; francesco.giorgino@uniba.it.

Comment

Francesco Giorgino. Evid Based Med. 2014 Dec.

. 2014 Dec;19(6):210.

doi: 10.1136/ebmed-2014-110010. Epub 2014 Jul 15.

¹ Department of Emergency and Organ Transplantation, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Piazza Giulio Cesare, 11, Bari 70124, Italy; francesco.giorgino@uniba.it.

No abstract available

Comment on

Effects of randomization to intensive glucose control on adverse events, cardiovascular disease, and mortality in older versus younger adults in the ACCORD Trial.
Miller ME, Williamson JD, Gerstein HC, Byington RP, Cushman WC, Ginsberg HN, Ambrosius WT, Lovato L, Applegate WB; ACCORD Investigators. Miller ME, et al. Diabetes Care. 2014;37(3):634-43. doi: 10.2337/dc13-1545. Epub 2013 Oct 29. Diabetes Care. 2014. PMID: 24170759 Free PMC article. Clinical Trial.